|
Sidec Technologies, Stockholm, Sweden and The
Center for Biophysical Sciences and Engineering (CBSE) located at
The University of Alabama at Birmingham announced a joint
collaboration to offer an extensive solution for structure based
drug design.
Sidec and the CBSE have entered into a co-marketing agreement where
they are offering combined research services for pharma and biotech,
to accelerate their drug discovery process. The solution combines
CBSE’s expertise in structure based drug discovery with Sidec’s
methods to rapidly define the structure function relationships of
membrane protein targets as well as biotherapeutic molecules.
Mr. Gosta Sjoholm, CEO of Sidec Technologies AB commented, “The
alliance with CBSE represents a significant progress in Sidec’s new
strategic direction. Together with CBSE we can formulate a very
competitive offer to our clients. It is an important step in
fulfilling our vision of bridging biology and chemistry, and for
establishing our solutions on the US market. Through combining
Sidec’s analysis of proteins in biological contexts with the CBSE
technologies, we can shortcut the process of finding amply evaluated
membrane targets and highly functional lead molecules”.
“Our expertise in determining structure/function relationships with
high throughput x ray crystallography provides a complimentary
approach to other highly effective tools such as Sidec’s rapid
electron tomography method for researchers seeking information on
protein characterization and visualization”, said Dr. Larry DeLucas,
Director of CBSE.
About The Center for Biophysical Sciences and Engineering
Since 1986, The CBSE has been dedicated to determining the
structure/function of biological molecules supporting structural
proteomics and drug design methodology for chronic and infectious
diseases. We have integrated our high throughput technologies in
structure based drug discovery and x-ray crystallography to embrace
the genes to drugs paradigm by attaining both speed and accuracy in
the identification, optimization and development of new therapeutics
that are central to modern pharmaceutical research and development.
The CBSE is located on the campus of The University of Alabama at
Birmingham. Please visit our website:
www.cbse.uab.edu.
About Sidec Technologies AB
Sidec Technologies provides solutions for the rapid studies of
protein conformation and interactions, based on the company’s
proprietary 3-D reconstruction technology and electron tomography.
With offices in Stockholm, Sweden and San Diego, California, Sidec
offers contract research services for analysis of membrane bound
proteins as well as studies of proteins in solution, to be used in
drug discovery. Main investors are the Karolinska Investment Fund
and Industrifonden. For more information, please visit
www.sidectech.com
The press release in PDF
Media information
Logos, company descriptions, images etc can be downloaded
here.
The Center for Biophysical Sciences and Engineering
Website:
www.cbse.uab.edu
Ms. Sharney Logan
Director of Business Development
Tel: +1 205-975-9590
E-Mail: Logan@cbse.uab.edu
Sidec Technologies AB
Mr. Gösta Sjöholm
CEO
Tel: +46 8 508 845 21
E-mail: gosta.sjoholm@sidectech.se
Disclaimer
Statements in this press release that are not strictly historical
are "forward-looking" statements, which involve a high degree of
risk and uncertainty. Such statements are only predictions, and the
actual events or results may differ materially from those projected
in such forward-looking statements.
|
|
